Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 1993 / Article

Open Access

Volume 4 |Article ID 572607 | https://doi.org/10.1155/1993/572607

Jutta K Preiksatis, "Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 4, Article ID 572607, 8 pages, 1993. https://doi.org/10.1155/1993/572607

Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients

Abstract

Over the past decade, significant progress has been made in the understanding of the molecular biology of cytomegalovirus (CMV) and the pathogenesis of CMV infection and disease. The introduction of antiviral agents with efficacy against CMV, coupled with rapid diagnostic techniques in the laboratory, have resulted in the design of a number of regimens lo prevent, modify and treat CMV infections in transplant recipients. Strategies for preventing CMV infection, including donorrecipient matching, the use of CMV 'safe' cellular blood products, passive and active immunization, and prophylactic antiviral drugs are discussed. Clinical trials of antiviral drugs alone. or in combination with immunoglobulin for the treatment of CMV disease are reviewed.

Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views591
Downloads523
Citations

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.